|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 31.34 USD | -0.25% |
|
+7.11% | +1.75% |
| 08-12 | BNP Paribas Initiates Genmab at Outperform, With $40 Price Target | MT |
| 08-12 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 70.1B | AAA | |||||||
| 54.93B | A | |||||||
| 28.89B | - | A | - | - | ||||
| 23.9B | AAA | |||||||
| 23.3B | - | - | - | - | ||||
| 18.41B | AA | |||||||
| 18.77B | A | |||||||
| 16.1B | - | AA | - | - | ||||
| 12.48B | BB | |||||||
| 12.32B | - | BB | - | - | ||||
| 12.39B | - | B | - | - | ||||
| 12.05B | - | - | - | - | ||||
| 11.98B | B | - | ||||||
| 10.52B | - | AA | - | - | ||||
| 8.99B | - | |||||||
| 9.18B | - | BB | - | - | - | |||
| 8.96B | - | BBB | - | - | ||||
| 8.88B | - | BBB | - | - | ||||
| 8.2B | - | CCC | - | - | ||||
| Average | 19.49B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
